Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.License Agreement • January 2nd, 2014 • uniQure B.V. • Pharmaceutical preparations
Contract Type FiledJanuary 2nd, 2014 Company IndustryWHEREAS AVENTIS is the owner of the certain patents relating to the preparation and use of recombinant viruses in gene therapy.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.License Agreement • November 8th, 2013 • uniQure B.V. • Pharmaceutical preparations
Contract Type FiledNovember 8th, 2013 Company IndustryWHEREAS AVENTIS is the owner of the certain patents relating to the preparation and use of recombinant viruses in gene therapy.